49 development-"https:"-"https:"-"https:"-"IMEDEA-CSIC-UIB" Postdoctoral positions in Sweden
Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
will also use focussed ion beam milling scanning electron microscopy (FIB-SEM) to prepare infected cells for in situ cryo-ET. The resulting tomographic data will be analysed by machine-learning assisted
-
). The project focuses on developing computational models for cancer risk assessment, integrating multiple types of data and risk factors. The main objective is to design and apply machine learning and deep
-
and development for all employees. We are also committed to building a safe and positive environment for all employees through mutual respect and tolerance. Description of the project The position
-
, you will examine new standard threats to human rights, aiming to develop a model for what human rights need to be able to address in a new era. The work involves some travel – to conferences as
-
or sources of CO2 and other greenhouse gases? 2) Is this status changing with global change, and if so, in what direction? In the project we will develop low-cost sensors to obtain high-resolution measurements
-
their aggregation and fibril formation. These systems are characterized using both purified and complex samples. The work is focussed on the development of a universal cryo-Cage for structural analysis of refractory
-
, compact heat exchangers, polymer and metal AM components, and advanced aerospace thermal. This postdoctoral project focuses on developing high-fidelity heat-transfer and fluid-flow models for AM-induced
-
credits for the voluntary market. Key responsibilities include: Conducting fieldwork and developing extensive case studies to analyse how data, carbon credits and financial resources circulate among actors
-
outside Europe. Collect and analyze high-quality data. Develop your own research questions within the framework of the project. Participate in regular project meetings and collaborate closely with other
-
consists in you independently developing in vivo reprogramming of tumor cells into cDC1-like cells using RNA vectors, with the ultimate goal to develop an off-the-shelf, safe, and scalable immunotherapy